Optimization of Processive Enzymes for DNA Sequencing using Nanopores

使用纳米孔优化 DNA 测序的加工酶

• 批准号: 8183739
• 负责人: MARK A AKESON
• 金额: $ 129.17万
• 依托单位: UNIVERSITY OF CALIFORNIA SANTA CRUZ
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-08-15 至 2014-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8183739
• 关键词: Area; Back; Biological; California; Centromere; Collaborations; Cytosine; DNA; DNA Sequence; DNA amplification; DNA biosynthesis; DNA-Directed DNA Polymerase; Detection; Devices; Engineering; Environment; Enzymes; Epigenetic Process; Excision; Fluorescence; Genetic; Genome; Genomics; Goals; Hemolysin; Human; Human Resources; Individual; Knowledge; Laboratories; Length; Medicine; Membrane; Methods; Methylation; Modification; Molecular; Motion; Motor; Movement; Noise; Nucleotides; Organism; Pennsylvania; Polymerase; Population; Predisposition; Proteins; Reading; Research; Resistance; Resolution; Saline; Signal Transduction; Single-Stranded DNA; Sodium Chloride; Solutions; Speed; Staging; Structure; Technology; Testing; Thick; Time; Universities; Viral; Washington; Work; active control; akeson; base; cost; detector; dinitroaminophenol; improved; information gathering; innovation; meetings; nanopore; novel; research study; sensor; silicon nitride; solid state; success; trait; viral DNA

DESCRIPTION (provided by applicant): The long-term objective of this project is rapid, highly accurate, and inexpensive sequencing of long (up to 150 kb) single DNA strands with a nanopore based DNA sequencing device. Meeting this long-term objective requires precise control of DNA movement past a nanopore sequence detector, and improvement of nanopore sequence detector resolution between DNA bases. The specific aims of this proposal build upon progress made to date in these two areas by laboratories at the University of California, Santa Cruz (Akeson), University of Washington (Gundlach) and the University of Pennsylvania (Drndic). Individual laboratory expertise and knowledge will be integrated to accomplish four specific aims. Specific aim one extends promising results at UCSC with DNA polymerase Phi29, a "molecular step motor" able to precisely control DNA movement through a nanopore sequencer. This work will employ existing personnel and 12 years of success at UCSC with alpha hemolysin protein nanopores to extend understanding of Phi29 DNA polymerase function in a nanopore. Specific aim two evaluates Phi29 DNA polymerase function with two nanopores selected for their potentially superior base resolution to the alpha hemolysin nanopore. The first is MspA, a protein nanopore, which will be evaluated with Phi29 DNA polymerase by U of Washington and UCSC teams. This collaboration takes advantage of expertise with use of Phi29 DNAP at UCSC and expertise with MspA at U of Washington. The second nanopore, a solid state ultrathin silicon nitride pore with fluorescence detection, will be evaluated with Phi29 DNA polymerase by U of Penn (makers of the solid-state nanopore) and UCSC teams. The third specific aim improves DNA base resolution through increased differences in current signals from individual bases. This will be achieved by increased salt concentrations in the nanopore combined with use of salt tolerant DNA Polymerases. DNA polymerases from salt tolerant organisms will be isolated by extremophile experts currently at UCSC. Specific aim 4 will use all information gathered to generate proof of concept through sequencing of long (up to 48 KB) DNA strands using a nanopore sequencing device. Realization of this technology will provide the basis for a more complete understanding of individual genetic traits and predispositions in human and other populations. PUBLIC HEALTH RELEVANCE: This proposal develops nanopore based DNA sequencing for significant improvement in speed and fidelity of DNA sequencing over current technologies. The ultimate goal is sufficient speed and cost reduction to permit routine sequencing of individual genomes and ultimately provide the basis for a detailed understanding of individual genetic traits and predispositions. This understanding and technology are needed for personalized medicine in the 21st century.

描述（由申请人提供）：该项目的长期目标是使用基于纳米孔的DNA测序装置对长（高达150 kb）单链DNA进行快速、高度准确和廉价的测序。满足这一长期目标需要精确控制DNA移动通过纳米孔序列检测器，并提高DNA碱基之间的纳米孔序列检测器分辨率。这项建议的具体目标是建立在加州大学、圣克鲁斯（Akeson）、华盛顿大学（Gundlach）和宾夕法尼亚大学（Drndic）实验室迄今在这两个领域取得的进展的基础上。个人实验室的专业知识和知识将被整合，以实现四个具体目标。具体目标之一是利用DNA聚合酶Phi29在UCSC扩展有希望的结果，Phi29是一种能够精确控制DNA通过纳米孔测序仪移动的“分子步进马达”。这项工作将利用UCSC现有的人员和12年的成功经验，利用α溶血素蛋白纳米孔来扩展对纳米孔中Phi29 DNA聚合酶功能的理解。具体目标二评价了Phi29 DNA聚合酶功能，其中选择了两个纳米孔，因为它们潜在地优于α溶血素纳米孔的上级碱基分辨率。第一个是MspA，一种蛋白质纳米孔，将由华盛顿大学和UCSC团队用Phi29 DNA聚合酶进行评估。这种合作利用了UCSC使用Phi29 DNAP的专业知识和华盛顿大学MspA的专业知识。第二个纳米孔，一个带有荧光检测的固态氮化硅孔，将由宾夕法尼亚大学（固态纳米孔的制造商）和UCSC团队用Phi29 DNA聚合酶进行评估。第三个具体目标是通过增加来自单个碱基的电流信号的差异来提高DNA碱基分辨率。这将通过增加纳米孔中的盐浓度并结合使用耐盐DNA聚合酶来实现。来自耐盐生物的DNA聚合酶将由目前在UCSC的极端微生物专家分离。具体目标4将使用收集的所有信息，通过使用纳米孔测序装置对长（高达48 KB）DNA链进行测序来生成概念证明。这项技术的实现将为更全面地了解人类和其他人群的个体遗传特征和倾向提供基础。 公共卫生相关性：该提案开发了基于纳米孔的DNA测序，以显著提高DNA测序的速度和保真度。最终的目标是足够的速度和成本降低，允许个人基因组的常规测序，并最终提供了一个详细的了解个人的遗传特征和倾向的基础。这种理解和技术是21世纪世纪个性化医疗所需要的。